Showing results (1491-1500 of 1,996) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|June 14, 2024
Recent advances in diagnosing, managing, and understanding the pathophysiology of cluster headacheAnja S Petersen, Nunu Lund, Peter J Goadsby, et al.
The Lancet. Neurology|June 14, 2024
Glioblastoma and brain connectivity: the need for a paradigm shiftAlessandro Salvalaggio, Lorenzo Pini, Alessandra Bertoldo, et al.
The Lancet. Neurology|May 19, 2024
Safety and efficacy of active blood-pressure reduction to the recommended thresholds for intravenous thrombolysis in patients with acute ischaemic stroke in the Netherlands (TRUTH): a prospective, observational, cluster-based, parallel-group studyThomas P Zonneveld, Sarah E Vermeer, Erik W van Zwet, et al.
The Lancet. Neurology|May 17, 2024
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trialBruce A C Cree, Ho Jin Kim, Brian G Weinshenker, et al.
The Lancet. Neurology|June 23, 2024
Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the NetherlandsIlse Huijberts, Florentina M E Pinckaers, Susanne G H Olthuis, et al.
The Lancet. Neurology|December 13, 2025
The gut microbiome, systemic inflammation, and autoimmunity in Parkinson's diseaseMatheus de Castro Fonseca, Letizia Zanetti, Stavros Fanourakis, et al.
The Lancet. Neurology|April 17, 2024
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional studyJulie K Wisch, Nicole S McKay, Anna H Boerwinkle, et al.
The Lancet. Neurology|December 15, 2023
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trialAndrew McGarry, Shane Rosanbalm, Mika Leinonen, et al.
The Lancet. Neurology|April 16, 2022
Tuberculous meningitis: progress and remaining questionsJulie Huynh, Joseph Donovan, Nguyen Hoan Phu, et al.
The Lancet. Neurology|June 19, 2026
Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapiesJan D Luünemann, Christian Münz
Pageof 200